Download Brochures
Contact Us
Address
C 107, Sumel Business Park 6, Dudheshwar Road, Shahibaug, Ahmedabad, Gujarat-380004, India.
Mobile
+91 9898069199
+91 9898591099
Email
info@suretyhealthcare.com
C 107, Sumel Business Park 6, Dudheshwar Road, Shahibaug, Ahmedabad, Gujarat-380004, India.
Mobile
+91 9898069199
+91 9898591099
info@suretyhealthcare.com


TABLETS
| No | Product | Drug Class | Mode of Action |
| 1 | Tenofovir Disoproxil Fumarate 300 mg Tablet | Antiretroviral (Nucleotide Reverse Transcriptase Inhibitor - NtRTI) | Converted intracellularly to tenofovir diphosphate, which inhibits HIV reverse transcriptase and causes viral DNA chain termination. |
| 2 | Lamivudine 300 mg Tablet | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Inhibits HIV reverse transcriptase by acting as a nucleoside analogue, resulting in termination of viral DNA synthesis. |
| 3 | Efavirenz 600 mg Tablet | Antiretroviral (Non-Nucleoside Reverse Transcriptase Inhibitor - NNRTI) | Directly binds to and inhibits HIV-1 reverse transcriptase, preventing viral RNA conversion into DNA. |
| 4 | Zidovudine 300 mg Tablet | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Acts as a thymidine analogue that inhibits reverse transcriptase and terminates viral DNA chain elongation. |
| 5 | Abacavir 300 mg Tablet | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Inhibits HIV reverse transcriptase after intracellular activation, preventing viral DNA synthesis. |
| 6 | Nevirapine 200 mg Tablet | Antiretroviral (Non-Nucleoside Reverse Transcriptase Inhibitor - NNRTI) | Non-competitively inhibits HIV reverse transcriptase, blocking viral replication. |
| 7 | Emtricitabine 200 mg Tablet | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Inhibits HIV reverse transcriptase and terminates viral DNA chain synthesis. |
| 8 | Dolutegravir 50 mg Tablet | Antiretroviral (Integrase Strand Transfer Inhibitor - INSTI) | Inhibits HIV integrase enzyme, preventing integration of viral DNA into the host genome. |
| 9 | Raltegravir 400 mg Tablet | Antiretroviral (Integrase Strand Transfer Inhibitor - INSTI) | Blocks HIV integrase-mediated insertion of viral DNA into host cell DNA. |
| 10 | Atazanavir 300 mg Capsule | Antiretroviral (Protease Inhibitor - PI) | Inhibits HIV protease enzyme, preventing maturation of infectious viral particles. |
| 11 | Ritonavir 100 mg Tablet | Antiretroviral (Protease Inhibitor - PI) / Pharmacokinetic Enhancer | Inhibits HIV protease and strongly inhibits CYP3A4, boosting plasma concentrations of other protease inhibitors. |
| 12 | Darunavir 600 mg Tablet | Antiretroviral (Protease Inhibitor - PI) | Inhibits HIV protease, preventing cleavage of viral polyproteins and formation of mature virions. |
| 13 | Lopinavir 200 mg + Ritonavir 50 mg Tablet | Antiretroviral Combination (Protease Inhibitors) | Lopinavir inhibits HIV protease to prevent viral maturation; ritonavir boosts lopinavir levels by inhibiting CYP3A4 metabolism. |
FIXED DOSE COMBINATION (FDC) TABLETS
| No | Product | Drug Class | Mode of Action |
| 1 | Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg + Efavirenz 600 mg Tablet | Antiretroviral Combination (2 NRTIs + 1 NNRTI) | Tenofovir and lamivudine inhibit HIV reverse transcriptase and terminate viral DNA synthesis, while efavirenz directly inhibits reverse transcriptase activity, suppressing viral replication. |
| 2 | Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg Tablet (TLD) | Antiretroviral Combination (2 NRTIs + 1 INSTI) | Tenofovir and lamivudine inhibit reverse transcriptase; dolutegravir blocks HIV integrase, preventing integration of viral DNA into host cells. |
| 3 | Zidovudine 300 mg + Lamivudine 150 mg Tablet | Antiretroviral Combination (2 NRTIs) | Both agents act as nucleoside analogues that inhibit HIV reverse transcriptase and terminate viral DNA chain elongation. |
| 4 | Zidovudine 300 mg + Lamivudine 150 mg + Nevirapine 200 mg Tablet | Antiretroviral Combination (2 NRTIs + 1 NNRTI) | Zidovudine and lamivudine inhibit viral DNA synthesis, while nevirapine non-competitively inhibits HIV reverse transcriptase. |
| 5 | Abacavir 600 mg + Lamivudine 300 mg Tablet | Antiretroviral Combination (2 NRTIs) | Both drugs inhibit HIV reverse transcriptase after intracellular activation, preventing viral DNA formation. |
| 6 | Abacavir 600 mg + Lamivudine 300 mg + Dolutegravir 50 mg Tablet | Antiretroviral Combination (2 NRTIs + 1 INSTI) | Abacavir and lamivudine inhibit reverse transcriptase, while dolutegravir prevents integration of viral DNA into the host genome. |
| 7 | Emtricitabine 200 mg + Tenofovir Disoproxil Fumarate 300 mg Tablet | Antiretroviral Combination (NRTI + NtRTI) | Both agents inhibit HIV reverse transcriptase, resulting in termination of viral DNA synthesis and suppression of viral replication. |
| 8 | Emtricitabine 200 mg + Tenofovir Disoproxil Fumarate 300 mg + Efavirenz 600 mg Tablet | Antiretroviral Combination (NRTI + NtRTI + NNRTI) | Emtricitabine and tenofovir inhibit viral DNA synthesis; efavirenz directly inhibits reverse transcriptase enzyme activity. |
| 9 | Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg Tablet | Antiretroviral Combination (NRTI + NtRTI) | Emtricitabine inhibits reverse transcriptase, while tenofovir alafenamide delivers intracellular tenofovir that blocks viral DNA synthesis. |
| 10 | Bictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg Tablet | Antiretroviral Combination (INSTI + NRTI + NtRTI) | Bictegravir inhibits HIV integrase, preventing viral DNA integration; emtricitabine and tenofovir alafenamide inhibit reverse transcriptase and terminate viral DNA synthesis. |
PEDIATRIC FORMULATIONS
| No | Product | Drug Class | Mode of Action |
| 1 | Abacavir Oral Solution | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | After intracellular activation, abacavir inhibits HIV reverse transcriptase, preventing viral DNA synthesis and replication. |
| 2 | Lamivudine Oral Solution | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Acts as a nucleoside analogue that inhibits HIV reverse transcriptase, resulting in termination of viral DNA chain elongation. |
| 3 | Zidovudine Oral Solution | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Inhibits HIV reverse transcriptase and terminates viral DNA synthesis by acting as a thymidine analogue. |
| 4 | Nevirapine Oral Suspension | Antiretroviral (Non-Nucleoside Reverse Transcriptase Inhibitor - NNRTI) | Directly binds to and inhibits HIV-1 reverse transcriptase, blocking viral replication. |
| 5 | Lopinavir + Ritonavir Oral Solution | Antiretroviral Combination (Protease Inhibitors) | Lopinavir inhibits HIV protease, preventing maturation of viral particles; ritonavir boosts lopinavir levels by inhibiting CYP3A4 metabolism. |
| 6 | Abacavir + Lamivudine Dispersible Tablets | Antiretroviral Combination (2 NRTIs) | Both agents inhibit HIV reverse transcriptase after intracellular activation, preventing viral DNA formation and replication. |
| 7 | Dolutegravir Dispersible Tablets | Antiretroviral (Integrase Strand Transfer Inhibitor - INSTI) | Inhibits HIV integrase enzyme, preventing integration of viral DNA into the host cell genome and blocking viral replication. |
CAPSULES
| No | Product | Drug Class | Mode of Action |
| 1 | Atazanavir Capsules | Antiretroviral (Protease Inhibitor - PI) | Inhibits HIV protease enzyme, preventing cleavage of viral polyproteins and formation of mature infectious virions. |
| 2 | Ritonavir Capsules | Antiretroviral (Protease Inhibitor - PI) / Pharmacokinetic Enhancer | Inhibits HIV protease and strongly inhibits CYP3A4, increasing plasma concentrations of co-administered protease inhibitors. |
| 3 | Darunavir Capsules | Antiretroviral (Protease Inhibitor - PI) | Inhibits HIV protease, preventing maturation of viral particles and reducing viral replication. |
ORAL SOLUTIONS / SUSPENSIONS
| No | Product | Drug Class | Mode of Action |
| 1 | Lamivudine Oral Solution | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Acts as a nucleoside analogue that inhibits HIV reverse transcriptase, resulting in termination of viral DNA synthesis. |
| 2 | Zidovudine Oral Solution | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Inhibits HIV reverse transcriptase and terminates viral DNA chain elongation after intracellular activation. |
| 3 | Abacavir Oral Solution | Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI) | Inhibits HIV reverse transcriptase, preventing viral DNA synthesis and replication. |
| 4 | Nevirapine Oral Suspension | Antiretroviral (Non-Nucleoside Reverse Transcriptase Inhibitor - NNRTI) | Directly binds to HIV-1 reverse transcriptase and blocks viral replication. |
| 5 | Lopinavir + Ritonavir Oral Solution | Antiretroviral Combination (Protease Inhibitors) | Lopinavir inhibits HIV protease to prevent viral maturation; ritonavir boosts lopinavir exposure by inhibiting CYP3A4 metabolism. |
